Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer

Case Comprehensive Cancer Center (Case CCC)

Status: Withdrawn

Conditions: Uterine Cancer

Treatments: Behavioral: Virtual visit; Behavioral: Office visit

Study type: Interventional

Funder types: Other

Identifiers

NCT03583736

CASE3818

Details and patient eligibility

About

This project aims to evaluate whether rapid first contact with the oncologist the same day or the next day after pathologic diagnosis contributes to a decreased time to treatment, decreased patient anxiety and increased patient satisfaction.

Full description

Time to treatment (time from disease diagnosis to initiation of treatment) impacts outcomes in uterine cancer. When controlled for stage, patients with longer time to treatment tend to have less favorable outcomes. Similarly, longer time to treatment has a negative impact on patients' quality of life and markers for anxiety. Our experience at this institution suggests that the time to referral (time from uterine cancer diagnosis and the patients' first encounter with the oncologist) is variable and presents the greatest opportunity for decreasing time to treatment. Among the factors that contribute to the time to referral are the time taken by the referring provider to relay the diagnosis to the patient, time taken to schedule an appointment with the specialist, and the patient's availability to keep an appointment.

Virtual visits provide an opportunity to expedite consultation with the treating oncologist by removing some of the barriers that delay face-to-face visits. Among these barriers are patients' availability for a short notice face-to-face visit based on their work or family obligations, access to transportation, and mental preparedness.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Uterine cancer diagnosis on biopsy read by Cleveland Clinic Pathology Department
• Patients must be willing to participate in a virtual visit as the initial meeting with an oncologist at the Cleveland Clinic.
• Receive care at Fairview Hospital, Hillcrest Hospital or Cleveland Clinic Main Campus
• Internet connected smartphone or internet connected computer with webcam
• Participants must have email access
• English speaking
• Competent to make clinic decisions

Exclusion criteria

• No diagnosis of uterine cancer

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups, including a placebo group

Rapid first contact virtual visit

Active Comparator group

Description:

Subjects will accept the offer of a virtual visit after being contacted by the nurse to offer a virtual visit with the oncologist prior to the in person office visit once a diagnosis has been confirmed. Subjects will be randomized after accepting offer of a virtual visit.

Treatment:

Behavioral: Virtual visit

First contact in person office visit

Placebo Comparator group

Description:

Subjects will accept the offer of a virtual visit after being contacted by the nurse to offer a virtual visit with the oncologist prior to the in person office visit once a diagnosis has been confirmed. Subjects will be randomized after accepting offer of a virtual visit.

Treatment:

Behavioral: Office visit